Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Prolonged administration of interferon-alpha in patients with chronic- phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome

DW Beelen, U Graeven, AH Elmaagacli, N Niederle, O Kloke, B Opalka, UW Schaefer

Blood (1995) 85 (10): 2981–2990.

https://doi.org/10.1182/blood.V85.10.2981.bloodjournal85102981

Published: 1995

Journal Articles

No correlation between the type of bcr-abl hybrid messenger RNA and platelet counts in chronic myelogenous leukemia [letter]

B Opalka, UB Wandl, R Stutenkemper, O Kloke, S Seeber, N Niederle

Blood (1992) 80 (7): 1854–1855.

https://doi.org/10.1182/blood.V80.7.1854.1854

Published: 1992

Journal Articles

Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gamma

B Opalka, UB Wandl, R Becher, O Kloke, M Nagel-Hiemke, T Moritz, U Beer, S Seeber, N Niederle

Blood (1991) 78 (9): 2188–2193.

https://doi.org/10.1182/blood.V78.9.2188.2188

Published: 1991

Journal Articles

A PvuII polymorphism of the bcr region in patients with hematopoietic disorders and their families

B Opalka, U Wandl, O Kloke, C Oberle, J Koppe, N Niederle, CG Schmidt

Blood (1989) 73 (3): 814–817.

https://doi.org/10.1182/blood.V73.3.814.814

Published: 1989